Navidea Biopharmaceuticals

(OTC) NAVBQ

Current Price$0.00

Market Cap$10.00K

Since IPO (1992)-100%

5 Year-100%

1 Year-90%

1 Month+9,900%

Navidea Biopharmaceuticals Financials at a Glance

Market Cap

$10.00K

Revenue (TTM)

$610.00

Net Income (TTM)

-$1.18M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

2851.63 (High)

Dividend

$0.00

Beta (Volatility)

2851.63 (High)

Price

$0.00

Volume

201

Open

$0.00

Price

$0.00

Volume

201

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.04

Estimated Earnings Date

Jun 11, 2026

Dividend

$0.00

Beta (Volatility)

2851.63 (High)

Price

$0.00

Volume

201

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.04

Estimated Earnings Date

Jun 11, 2026

NAVBQ News

Page 1

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Navidea Biopharmaceuticals

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Michael S. Rosol, PhD

Website

www.navidea.com

Headquarters

Dublin, OH 43017-3552, US

NAVBQ Financials

Key Financial Metrics (TTM)

Gross Margin

-259.40%

Operating Margin

-21402.08%

Net Income Margin

-23117.58%

Return on Equity

355.34%

Return on Capital

N/A

Return on Assets

-347.18%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$10.00K

Shares Outstanding

100.08M

Volume

201

Avg. Volume

12.56K

Financials (TTM)

Gross Profit

-$158.38K

Operating Income

-$10.18M

EBITDA

-$8.89M

Operating Cash Flow

-$9.71M

Capital Expenditure

-$193.31K

Free Cash Flow

-$9.91M

Cash & ST Invst.

$3.86M

Total Debt

$1.26M

Navidea Biopharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q3 2023YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

-$36.03K

+71.6%

Gross Margin

0.00%

N/A

Market Cap

$10.00K

N/A

Market Cap/Employee

$909.09

N/A

Employees

N/A

Net Income

-$2.26M

+60.5%

EBITDA

-$2.10M

+62.3%

Quarterly Fundamentals

Name

Q3 2023YOY CHG

Total Cash

$3.86M

-16.0%

Total Debt

$1.26M

-30.8%

Accounts Receivable

$30.87K

-80.1%

Inventory

$460.75K

+137.7%

Long Term Debt

$269.00

-100.0%

Short Term Debt

$1.26M

+2202.9%

Return on Assets

-3.47%

N/A

Return on Invested Capital

2.52%

N/A

Free Cash Flow

-$10.27M

-430.0%

Operating Cash Flow

-$10.25M

-451.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

NNMXNanomix Corporation

NNMXNanomix Corporation$0.00+0.00%

GLSHQGelesis Holdings, Inc.

GLSHQGelesis Holdings, Inc.$0.00+0.00%

CRXMGene Biotherapeutics, Inc.

CRXMGene Biotherapeutics, Inc.$0.00+9900.00%

GNBTGenerex Biotechnology Corporation

GNBTGenerex Biotechnology Corporation$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$33.25-0.03%

NVDANvidia

NVDANvidia$200.16+0.03%

NKENike

NKENike$41.07-0.01%

AAPLApple

AAPLApple$289.34+0.03%

AMZNAmazon

AMZNAmazon$238.51-0.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$81.00+0.05%

SMCISuper Micro Computer

SMCISuper Micro Computer$29.33+0.04%

Questions About NAVBQ

What is the current price of Navidea Biopharmaceuticals?

Navidea Biopharmaceuticals is trading at $0.00 per share.

What is the 52-week range for Navidea Biopharmaceuticals?

Over the past 52 weeks, Navidea Biopharmaceuticals has traded between $0.00 and $0.04.

How much debt does Navidea Biopharmaceuticals have?

As of the most recent reporting period, Navidea Biopharmaceuticals reported total debt of $2.44M.

How much cash does Navidea Biopharmaceuticals have on hand?

Navidea Biopharmaceuticals reported $2.00M in cash and cash equivalents in its most recent financial results.

What is Navidea Biopharmaceuticals’s dividend yield?

Navidea Biopharmaceuticals does not currently have a dividend yield.

Navidea Biopharmaceuticals

Navidea Biopharmaceuticals Financials at a Glance

NAVBQ News

This Week in Biotech: Actions Speak Louder Than Words

Why Navidea Biopharmaceuticals Inc. Shares Briefly Spiked Lower

Why Navidea Biopharmaceuticals Inc. Shares Jumped

Why Navidea Biopharmaceuticals, Inc. Shares Jumped

Why Navidea Biopharmaceuticals Inc. Shares Soared

3 Diagnostic Stocks That May See Sales Soar Because of Obamacare

3 Stocks to Get on Your Watchlist

The 5 Most Misdiagnosed Diseases

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Navidea Biopharmaceuticals

NAVBQ Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Navidea Biopharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About NAVBQ

What is the current price of Navidea Biopharmaceuticals?

What is the 52-week range for Navidea Biopharmaceuticals?

How much debt does Navidea Biopharmaceuticals have?

How much cash does Navidea Biopharmaceuticals have on hand?

What is Navidea Biopharmaceuticals’s dividend yield?

Premium Investing Services